Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of Curing Disease
March 10, 2017 at 14:33 PM EST
The pharmaceutical industry, rich with innovative players and shaken by impending regulatory changes, is a well-worn topic on Wall ...
